LALPATHLAB1,912.00

Dr. Lal Path Labs Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersMETROPOLISVIJAYATHYROCARENATCOPHARMNEULANDLABNHCOHANCESAILIFEMcap ₹32,045 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations2,226.62,461.42,762.92,890.8
Other Income69.293.4101.3105.1
Total Income2,295.82,554.82,864.22,995.9
Expenses
+ Cost of Materials Consumed451.4481.5534.6557.4
+ Employee Benefit Expense424.5482.4503.3528.2
+ Finance Costs29.422.322.824.4
+ Depreciation & Amortisation143.6141.9161.8171.6
+ Other Expenses741.4802.0942.5967.5
Total Expenses1,790.31,930.12,165.02,249.1
EBITDA609.3695.5782.5837.7
EBIT465.7553.6620.7666.1
Profit
PBT before Exceptional Items505.5624.7699.2746.8
+ Exceptional Items0.00.0-30.1-30.1
Pretax Income505.5624.7669.1716.7
+ Current Tax148.0172.0159.2173.9
+ Deferred Tax-4.8-39.50.1-3.5
Tax Expense143.2132.5159.3170.4
Net Income362.3492.2509.8546.3
+ Net Income — Continuing Ops362.3492.2509.8546.3
+ Other Comprehensive Income-0.6-3.65.27.5
Total Comprehensive Income361.7488.6515.0553.8
Net Income to Common357.7487.1504.8541.9
Minority Interest4.65.15.04.4
Per Share
Basic EPS43.0558.4830.2441.48
Diluted EPS42.9858.4030.2041.40
Other Comprehensive Income — detail
+ Other Comprehensive Income-3.65.27.5
+ Items NOT to be Reclassified to P&L-0.5-4.96.79.6
+ Tax on Items NOT to be Reclassified-1.31.72.4
+ Tax on Items NOT to be Reclassified — alt tag-0.1
+ Items to be Reclassified to P&L-0.20.00.20.3
Comprehensive Income — Owners of Parent357.2483.5510.0549.4
Comprehensive Income — Non-controlling Interests4.55.15.04.4
Per Share — as-filed variants
Basic EPS — Continuing Operations43.0558.4830.2441.48
Diluted EPS — Continuing Operations42.9858.4030.2041.40
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit1,775.21,979.92,228.32,333.4
Gross Margin %79.7380.4480.6580.72
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)505.5624.7699.2746.8
− Exceptional Items (reconciliation)0.00.0-30.1-30.1
Net Income Adj (tax-effected)362.3492.2532.7569.2
EPS Adj43.0558.4831.6043.22
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.00
Paid Up Equity Capital83.583.6167.6167.6
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.